Steven G. Deeks, MD, is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF). He is a recognized expert on HIV-associated immune dysfunction and its impact on HIV persistence (the “reservoir”) and health during antiretroviral therapy. Dr. Deeks has published over 500 peer-review articles, editorials and invited reviews on these and related topics. He has been the recipient of several NIH grants, and is one of the principal investigators of DARE (the Delaney AIDS Research Enterprise), which is an NIH-funded international collaboratory aimed at developing therapeutic interventions to cure HIV infection. He is also the principal investigator of amfAR Institute for HIV Cure Research. He was elected to the American Society for Clinical Investigation (ASCI) and the Association of America Physicians (AAP), is the editor-in-chief for Current Opinion in HIV and AIDS and serves on the scientific advisory board for Science Translational Medicine. In March, 2020, he leveraged his HIV research program to construct the “Long-term Impact of Infection with Novel Coronavirus (LIINC)” cohort, which is now supporting dozens of studies addressing the impact of SARS-CoV-2 on health In addition to his clinical and translational investigation, Dr. Deeks maintains a primary care clinic for HIV infected adults.
Steven G. Deeks, MD